2008 - Member of the National Academy of Medicine (NAM)
Her scientific interests lie mostly in Virology, Virus, Immunology, Acquired immunodeficiency syndrome and Viral disease. Her Virology research integrates issues from Gene and Cohort. Her Virus research is multidisciplinary, relying on both Antibody, Serology and Antigen.
Her Immunology research is multidisciplinary, incorporating elements of Internal medicine, Disease and Clade. Her work carried out in the field of Acquired immunodeficiency syndrome brings together such families of science as Infectivity, Survival analysis, Epidemiology and Cohort study. In her research on the topic of Viral disease, Generalized lymphadenopathy and Lymphocyte is strongly related with Immunopathology.
Her primary areas of study are Virology, Acquired immunodeficiency syndrome, Immunology, Virus and Internal medicine. The concepts of her Virology study are interwoven with issues in Antibody and Antigen. She works mostly in the field of Acquired immunodeficiency syndrome, limiting it down to topics relating to Odds ratio and, in certain cases, Logistic regression and Confidence interval, as a part of the same area of interest.
Her research combines Peripheral blood mononuclear cell and Immunology. The Virus study combines topics in areas such as Leukemia, Gene and In vivo. Her research in Internal medicine intersects with topics in Antiretroviral therapy, Viral load and Drug resistance.
Her primary areas of investigation include Internal medicine, Viral load, Retrospective cohort study, Cohort and Pediatrics. Phyllis J. Kanki has included themes like Nevirapine, Efavirenz, Drug resistance and Pharmacology in her Internal medicine study. Viral load is a subfield of Virus that Phyllis J. Kanki tackles.
Phyllis J. Kanki has researched Pediatrics in several fields, including Observational study, Acquired immunodeficiency syndrome, Antiretroviral therapy, Cohort study and Lost to follow-up. Her research in Pregnancy tackles topics such as Transmission which are related to areas like Immunology. Her work in Disease is not limited to one particular discipline; it also encompasses Virology.
Her main research concerns Internal medicine, Regimen, Acquired immunodeficiency syndrome, Viral load and Retrospective cohort study. Her studies deal with areas such as Efavirenz, Drug resistance and Pharmacology as well as Internal medicine. Her Drug resistance research includes themes of Genotypic resistance, HIV drug resistance, First line and Virology.
Her work on NS3 as part of general Virology study is frequently linked to Anthrax toxin, bridging the gap between disciplines. Her Regimen research incorporates themes from Immunology and Zidovudine. Many of her research projects under Acquired immunodeficiency syndrome are closely connected to Quality with Quality, tying the diverse disciplines of science together.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Isolation of T-cell tropic HTLV-III-like retrovirus from macaques
Daniel;NL Letvin;NW King;M Kannagi.
Science (1985)
Reduced rate of disease development after HIV-2 infection as compared to HIV-1
Richard Marlink;Phyllis Kanki;Ibou Thior;Karin Travers.
Science (1994)
Slower heterosexual spread of HIV-2 than HIV-1
P.J. Kanki;K.U. Travers;R.G. Marlink;M.E. Essex.
The Lancet (1994)
Human Immunodeficiency Virus Type 1 Subtypes Differ in Disease Progression
Phyllis J. Kanki;Donald J. Hamel;Jean-Louis Sankalé;Chung-cheng Hsieh.
The Journal of Infectious Diseases (1999)
New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).
P J Kanki;F Barin;S M'Boup;J S Allan.
Science (1986)
SEROLOGICAL EVIDENCE FOR VIRUS RELATED TO SIMIAN T-LYMPHOTROPIC RETROVIRUS III IN RESIDENTS OF WEST AFRICA
F. Barin;F. Denis;J.S. Allan;S. M'Boup.
The Lancet (1985)
Serologic identification and characterization of a macaque T-lymphotropic rétrovirus closely related to HTLV-III
P. J. Kanki;M. F. McLane;N. W. King;N. L. Letvin.
Science (1985)
Lower Human Immunodeficiency Virus (HIV) Type 2 Viral Load Reflects the Difference in Pathogenicity of HIV-1 and HIV-2
Stephen J. Popper;Abdoulaye Dieng Sarr;Karin U. Travers;Aissatou Guèye-Ndiaye.
The Journal of Infectious Diseases (1999)
Isolation of T-lymphotropic retrovirus related to HTLV-III/LAV from wild-caught African green monkeys
PJ Kanki;J Alroy;M Essex.
Science (1985)
A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients.
Jonathan S. Allan;John E. Coligan;Tun-Hou Lee;Mary Frances McLane.
Science (1985)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Institute of Health Research, Epidemiological Surveillance and Training
Harvard University
Northwestern University
François Rabelais University
University of KwaZulu-Natal
Stanford University
University of London
Institut de Recherche pour le Développement
University College London
Emory University
Utrecht University
Taiyuan University of Science and Technology
University of Malaya
University at Buffalo, State University of New York
Duke University
Yale University
Central South University
University of Ioannina
University of Copenhagen
Newcastle University
Oregon Health & Science University
University of Western Brittany
National Center for Atmospheric Research
Hannover Medical School
Black Dog Institute
San Diego State University